Rocket
Premium
Excel Add-In
International
Tools
Dashboard
Screener
Spinoffs
IPOs
Register
Alerts
Sign In
Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders
Insiders Menu
Roster
Transactions
POINT Biopharma Global Inc. (PNT)
Date
Name
Title
Type
Security
Shares
Price
Value
Ownership
Reported
06/01/2023
Lubner David Charles
Director
Grant
Stock Option (Right to Buy)
44.7k
$9.12
$408.1k
06/01/2023
06/01/2023
MARGOLIN YAEL
Director
Grant
Stock Option (Right to Buy)
44.7k
$9.12
$408.1k
06/01/2023
06/01/2023
GOODMAN JONATHAN R.
Director
Grant
Stock Option (Right to Buy)
44.7k
$9.12
$408.1k
06/01/2023
06/01/2023
HOGUE GERALD L.
Director
Grant
Stock Option (Right to Buy)
44.7k
$9.12
$408.1k
06/01/2023
06/01/2023
Malik Rajesh
Director
Grant
Stock Option (Right to Buy)
44.7k
$9.12
$408.1k
06/01/2023
03/28/2023
DEMERS WILLIAM L.
CFO
Grant
Stock Option (Right to Buy)
131.4k
$6.78
$890.6k
03/28/2023
03/28/2023
FLESHNER NEIL E.
Chief Medical Officer
Grant
Stock Option (Right to Buy)
84.3k
$6.78
$571.3k
03/28/2023
03/28/2023
JENSEN JESSICA D.
EVP Clinical Development
Grant
Stock Option (Right to Buy)
136.1k
$6.78
$922.5k
03/28/2023
03/28/2023
KELLY JUSTYNA
COO
Grant
Stock Option (Right to Buy)
98.4k
$6.78
$666.9k
03/28/2023
03/28/2023
MCCANN JOE A.
CEO
Grant
Stock Option (Right to Buy)
692.6k
$6.78
$4.7M
03/28/2023
03/28/2023
SILBER ALLAN C
Executive Chairman
Grant
Stock Option (Right to Buy)
537.3k
$6.78
$3.6M
03/28/2023
03/21/2023
HOGUE GERALD L.
Director
Exercise
Stock Option (Right to Buy)
17.9k
$6.97
$125k
03/21/2023
11/29/2022
MCCANN JOE A.
CEO
Purchase
Common Stock
2.2k
$6.64
$14.3k
11/29/2022
11/28/2022
Malik Rajesh
Director
Purchase
Common Stock
3.7k
$6.66
$24.6k
11/28/2022
11/25/2022
HOGUE GERALD L.
Director
Purchase
Common Stock
3.7k
$6.82
$24.9k
11/25/2022
11/23/2022
Lubner David Charles
Director
Purchase
Common Stock
3.6k
$6.85
$24.7k
11/23/2022
11/21/2022
MARGOLIN YAEL
Director
Purchase
Common Stock
1.7k
$6.56
$11.2k
11/21/2022
11/18/2022
SILBER ALLAN C
Executive Chairman
Purchase
Common Stock
22.4k
$6.50
$145.6k
11/17/2022
11/17/2022
SILBER ALLAN C
Executive Chairman
Purchase
Common Stock
27.6k
$6.00
$165.6k
11/17/2022
06/02/2022
Lubner David Charles
Director
Grant
Stock Option (Right to Buy)
25.6k
$8.31
$212.9k
06/02/2022
06/02/2022
Malik Rajesh
Director
Grant
Stock Option (Right to Buy)
25.6k
$8.31
$212.9k
06/02/2022
06/02/2022
MARGOLIN YAEL
Director
Grant
Stock Option (Right to Buy)
25.6k
$8.31
$212.9k
06/02/2022
06/02/2022
HOGUE GERALD L.
Director
Grant
Stock Option (Right to Buy)
25.6k
$8.31
$212.9k
06/02/2022
06/02/2022
GOODMAN JONATHAN R.
Director
Grant
Stock Option (Right to Buy)
25.6k
$8.31
$212.9k
06/02/2022
05/25/2022
FLESHNER NEIL E.
Chief Medical Officer
Sale
Common Stock
564.2k
$7.51
$4.2M
05/25/2022
04/01/2022
JENSEN JESSICA D.
EVP Clinical Development
Grant
Stock Option (Right to Buy)
13.8k
$7.91
$108.9k
04/01/2022
03/29/2022
KELLY JUSTYNA
COO
Grant
Stock Option (Right to Buy)
78k
$8.13
$633.8k
03/29/2022
03/29/2022
FLESHNER NEIL E.
Chief Medical Officer
Grant
Stock Option (Right to Buy)
60.2k
$8.13
$489.7k
03/29/2022
03/29/2022
MCCANN JOE A.
CEO
Grant
Stock Option (Right to Buy)
381.8k
$8.13
$3.1M
03/29/2022
03/29/2022
DEMERS WILLIAM L.
CFO
Grant
Stock Option (Right to Buy)
105.4k
$8.13
$856.6k
03/29/2022
03/29/2022
JENSEN JESSICA D.
EVP Clinical Development
Grant
Stock Option (Right to Buy)
213.3k
$8.13
$1.7M
03/29/2022
12/09/2021
KELLY JUSTYNA
COO
Grant
Stock Option (Right to Buy)
70k
$6.40
$448k
12/09/2021
07/06/2021
FLESHNER NEIL E.
Chief Medical Officer
Grant
Stock Option (Right to Buy)
25k
$8.47
$211.8k
07/06/2021
07/06/2021
Lubner David Charles
Director
Grant
Stock Option (Right to Buy)
25k
$8.47
$211.8k
07/06/2021
07/06/2021
GOODMAN JONATHAN R.
Director
Grant
Stock Option (Right to Buy)
25k
$8.47
$211.8k
07/06/2021
Next >>
Rocket Data Systems, Inc. © 2019 |
Contact Us
|
Data Disclaimer
|
Terms of Use
|
Privacy